This site is intended for health professionals only

Wednesday 19 June 2019
LatestNews
Share |

Latest News

Lynparza approved for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer

Tuesday 18th June 2019
AstraZeneca and MSD have announced that the European Commission (EC) has approved Lynparza (olaparib) as a 1st-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer.
 
The licensed indication is as a maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (...
Wed, 10 Apr 2019
In oncology, in particular, where there are often no alternatives to these medicines, shortages pose a threat to patient safety as they reduce adherence to therapy and limit the ability of physicians to provide effective treatment regimens
Wed, 10 Apr 2019
Those who qualified in the European Union (EU) can continue to practise in the UK after Brexit, even in a no-deal scenario, the Government has confirmed.
Wed, 10 Apr 2019
European health insurance cards (EHIC) may no longer be valid in the event of a no-deal Brexit, the Department of Health and Social Care has said.
Tue, 9 Apr 2019
NHS England has said it is going to ‘formally request’ that the Government bans GPs from prescribing homeopathy.
Mon, 8 Apr 2019
The European Centre for Disease Prevention and Control estimates that a severe pandemic could infect up to a quarter of the population of the European Union, with many millions of cases and tens of thousands of deaths
Mon, 8 Apr 2019
A clinical review published in the BMJ provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions
Fri, 5 Apr 2019
The UK medicines watchdog has issued guidance on fluoroquinolone antibiotics following some reports of ‘potentially irreversible’ side effects affecting multiple systems, organ classes and senses